News

Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...
First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...
Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.
Open Molecules 2025, an unprecedented dataset of molecular simulations, has been released to the scientific community, paving ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit and Frontier Science Foundation, announced ...
As the FDA prepares for a busy Oncologic Drugs Advisory Committee next week, an agency insider told BioSpace that volunteers ...
Genentech, American-headquartered in San Francisco, plans 420 jobs for the Wake County community of Holly Springs just outside of Raleigh.
Focused Research Symposium Highlighting Recent Innovations in the Field SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE ...
Kazia Therapeutics Limited ("Kazia" or the "Company"), an oncology-focused drug development company, today announced a summary of its recent progress across its business and also provided a business ...
Prolec-GE Waukesha, Inc., one of the nation's largest manufacturers of power transformers, is planning to build a second ...
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or ...
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in ...